A pilot study of treatment of lentigo maligna with 5% imiquimod cream.
about
Treatment of autoimmune inflammation by a TLR7 ligand regulating the innate immune systemA systematic review on the role of imiquimod in lentigo maligna and lentigo maligna melanoma: need for standardization of treatment schedule and outcome measures.In vitro analysis of acetalated dextran microparticles as a potent delivery platform for vaccine adjuvants.Use of imiquimod for residual acral melanomaImiquimod in the treatment of lentigo maligna.Additive melanoma suppression with intralesional phospholipid-conjugated TLR7 agonists and systemic IL-2.Observational study of topical imiquimod immunotherapy in the treatment of difficult lentigo maligna.Using topical imiquimod for the management of positive in situ margins after melanoma resection.A systematic review of non-surgical treatments for lentigo maligna.Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells.Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy.Hypopigmenting agents: an updated review on biological, chemical and clinical aspects.TLR7 and TLR8 as targets in cancer therapy.Modifying skin pigmentation - approaches through intrinsic biochemistry and exogenous agents.Dermatoscopy-guided therapy of pigmented basal cell carcinoma with imiquimod.Treatment options in melanoma in situ: topical and radiation therapy, excision and Mohs surgery.The cutaneous manifestations of metastatic malignant melanoma.Microinvasive melanoma: cutaneous pharmacotherapeutic approaches.Differential immunomodulatory activity of tumor cell death induced by cancer therapeutic toll-like receptor ligands.Imiquimod in dermatology: an overview.Peculiar clinical and dermoscopic remission pattern following imiquimod therapy of basal cell carcinoma in seborrhoeic areas of the face.Topical Imiquimod Treatment of Lentigo Maligna.[Remission of extensive lentigo maligna after treatment with imiquimod].
P2860
Q28484146-786DE13E-08F4-4DB4-8C34-70E2D6AEB50EQ30240021-505C3E8B-BB9B-4687-A54E-F2F057457BD2Q33901007-4E2C0A74-CEA9-497F-9A08-3FB68767C7F4Q34130648-A485C1BA-5C5E-44C1-BC30-67473ACB48B4Q34565175-18AA19B1-AAF0-4E6E-BE06-6E7E0862AF8FQ34672618-0562A1DF-27E0-44B9-AF0A-2D3F603819BEQ35181048-4531AA44-7142-4A85-A7AB-62D235A3E960Q35469297-88372AC5-E3CE-4D07-B4AD-5AD6E0AC1E24Q35753267-DEE307C6-D288-494D-B08C-8799ABA63479Q36229384-EC490D24-4C87-4006-90B7-2D18BB89B54BQ36373370-F46B0293-643A-44B9-8808-CB4CE8A2033EQ36643852-591F35BB-D2E8-44B5-9A17-65320759D6CEQ37051014-C43ADFA2-90C6-43A0-8B9D-7A2738EF4AF1Q37183418-C0B02DE6-403F-40CD-B6B8-3C12B79F964CQ37540424-82A55EAD-B81D-4730-A6C9-319AA71ADCA5Q37763742-D1DE39A6-F233-4AF9-B6B9-F209C22D2002Q37986185-EDFFC4B9-5C0E-4AE8-9A2B-904F3241A072Q38088212-B040A0E8-CDA5-41F1-BC83-1BB73CD3806FQ38781955-392BCCD2-5812-407F-8FB0-EE4E153957A8Q38888889-C8F70605-20DA-41FE-B4EF-86D07DC669A8Q40029334-4754780D-A063-4367-BDA4-7B0579016AA1Q42739797-6271C723-4111-42D5-904F-83903D8FBEA4Q46045312-E0761BB4-EFF2-496E-85EB-28D420BB1512
P2860
A pilot study of treatment of lentigo maligna with 5% imiquimod cream.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
A pilot study of treatment of lentigo maligna with 5% imiquimod cream.
@en
A pilot study of treatment of lentigo maligna with 5% imiquimod cream.
@nl
type
label
A pilot study of treatment of lentigo maligna with 5% imiquimod cream.
@en
A pilot study of treatment of lentigo maligna with 5% imiquimod cream.
@nl
prefLabel
A pilot study of treatment of lentigo maligna with 5% imiquimod cream.
@en
A pilot study of treatment of lentigo maligna with 5% imiquimod cream.
@nl
P2093
P2860
P1476
A pilot study of treatment of lentigo maligna with 5% imiquimod cream.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2133.2004.05983.X
P407
P577
2004-08-01T00:00:00Z